Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies-Reference-Cited by-同舟云学术

Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies

Published:2020-09-01 Issue:9 Volume:180 Page:1145
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Zhai Mike Z.¹,Lye Carolyn T.²³,Kesselheim Aaron S.¹

Affiliation:

1. Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

2. Yale School of Medicine, New Haven, Connecticut

3. Yale Law School, New Haven, Connecticut

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2766372/jamainternal_zhai_2020_vp_200015_1599079808.56207.pdf

Reference10 articles.

1. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.;Gautret;Int J Antimicrob Agents

2. Finding effective treatments for COVID-19: scientific integrity and public confidence in a time of crisis.;Goodman;JAMA

3. US Food and Drug Administration. Request for emergency use authorization for use of chloroquine phosphate or hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of 2019 coronavirus disease. Published March 28, 2020. Accessed April 12, 2020. https://www.fda.gov/media/136534/download

4. US Food and Drug Administration. Emergency use authorization of peramivir IV: fact sheet for health care providers. Accessed April 12, 2020. https://www.fda.gov/media/77787/download

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moralisation of medicines: The case of hydroxychloroquine;European Journal for Philosophy of Science;2023-08-16

2. Trust and Regulation: Assuring Scientific Independence in the FDA's Emergency Use Authorization Process;Journal of Health Politics, Policy and Law;2023-03-24

3. Mortality in children with cancer and SARS-CoV-2 in Latin America: A systematic review;Frontiers in Pediatrics;2022-08-09

4. Using Twitter data to understand public perceptions of approved versus off-label use for COVID-19-related medications;Journal of the American Medical Informatics Association;2022-07-18

5. Using Twitter data to understand public perceptions of approved versus off-label use for COVID-19-related medications;J AM MED INFORM ASSN;2022